Jean-Luc Bailly is currently a full lecturer at the University Clermont Auvergne (in virology, immunology, infectious diseases, and molecular epidemiology of viral diseases). His primary area of interest has been in human enterovirus infections. He is leading a research group on the epidemiology and pathophysiology of enterovirus diseases. In the Organovir consortium, he will supervise a PhD project to achieve the development of a 3D model of human blood-brain-barrier.
About the University Clermont Auvergne
Université Clermont Auvergne (UCA) is a multidisciplinary higher education institution located in Clermont-Ferrand, a city located in the middle of France. With 35,000 students, including 4,600 (13%) international ones, and 3,300 staff, UCA plays a key role in the territorial structuration and the building of a European level region. Its 20 Faculties and 5 Doctoral Schools offer more than 170 training programs.
It also hosts 39 research units and laboratories and is committed in several laboratory of excellence, regional clusters and competitiveness centres. The UCA and its regional partners are one of the 12 major research centres in France to have been awarded the I-Site label (in 2017) (Initiatives – Science – Innovation – Territories – Economy), which puts the Clermont-Ferrand university site on the map of excellence in higher education and research at national and international level.
UCA is participating to Organovir on behalf of the LMGE joint research unit between UCA and the ‘Centre National de la Recherche Scientifique’ (CNRS). Among the 6 teams of LMGE, the EPIE team takes part in the Organovir project.
The EPIE team works in close relationships with the department of medical virology and the National Reference Center (NRC) of enteroviruses and parechoviruses at the University hospital of Clermont-Ferrand. The activities of the NRC comprise the epidemiological and clinical surveillance of enterovirus infections.